MoneyWorks4Me

Shilpa Medicare informs about updates

28 Jul 2021 Evaluate

Shilpa Medicare has informed today about the receipt of confirmation of WHO-GENEVA approval for API, Tenofovir Disoproxil Fumarate, a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS, under pre-qualification program.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

817.50 -4.40 (-0.54%)
17-Aug-2026 10:33 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.65
Dr. Reddys Labs. 1195.15
Cipla 1432.70
Lupin 2225.00
Zydus Lifesciences 1143.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: